Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
CTAD 2022 – lecanemab data hold up, with a big but
EP Vantage
Thu, 12/1/22 - 07:01 pm
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
CTAD
,
lecanemab
,
clinical trials
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
Tags:
FDA
,
Mirati Therapeutics
,
Gilead Sciences
,
Coherus Biosciences
,
Roche
,
Biogen
,
TG Therapeutics
,
Ipsen
,
Novartis
,
BeiGene
,
Cytokinetics
What to make of Eisai and Biogen’s latest Alzheimer’s drug data
BioPharma Dive
Tue, 11/29/22 - 10:58 pm
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
lecanemab
Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal
Fierce Biotech
Mon, 11/28/22 - 07:51 pm
Tags:
Biogen
,
Eisai
,
clinical trials
,
patient death
,
lecanemab
,
Alzheimer's disease
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Tags:
Roche
,
Alzheimer's disease
,
gantenerumab
,
Biogen
,
Cassava Sciences
,
Eli Lilly
Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO
Medical Marketing and Media
Thu, 11/10/22 - 10:51 am
Tags:
Biogen
,
Pharma CEOs
,
Christopher Viehbacher
,
Chris Viehbacher
J&J vet Mammen wanted board influence to be Biogen's next CEO, but chairman said no
Fierce Pharma
Tue, 11/8/22 - 10:43 pm
Tags:
JNJ
,
Biogen
,
Pharma CEOs
,
Mathai Mammen
Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases
BioSpace
Mon, 11/7/22 - 10:52 am
Tags:
neurodegenerative disease
,
Biogen
,
BioAge Labs
,
PTC Therapeutics
MS Drug Advances from Merck, BMS and More Showcased at ECTRIMS Conference
BioSpace
Wed, 10/26/22 - 06:51 pm
Tags:
Merck
,
Biogen
,
Bristol Myers Squibb
,
MS
,
multiple sclerosis
,
ECTRIMS
Biogen's Q3 revenue declines 10% as focus shifts to new Alzheimer's and ALS drug candidates
Endpoints
Tue, 10/25/22 - 11:05 am
Tags:
Biogen
,
earnings
,
Alzheimer's disease
,
ALS
,
tofersen
,
lecanemab
Where Will Biogen Be in 5 Years?
Motley Fool
Thu, 10/20/22 - 10:39 am
Tags:
Biogen
,
Aduhelm
,
lecanemab
,
Alzheimer's disease
,
M&A
Biogen's ALS ambitions on pause as FDA delays approval decision by 3 months
Fierce Biotech
Mon, 10/17/22 - 10:53 am
Tags:
Biogen
,
tofersen
,
FDA
,
ALS
Sage, Biogen post fresh phase 3 depression data as FDA filing nears completion
Fierce Biotech
Mon, 10/17/22 - 10:39 am
Tags:
SAGE Therapeutics
,
Biogen
,
zuranolone
,
postpartum depression
,
clinical trials
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
Tags:
FDA
,
Biogen
,
Eisai
,
Alzheimer's disease
,
Gilead Sciences
,
HIV
,
Mirati Therapeutics
,
lung cancer
,
lecanemab
,
lenacapavir
,
adagrasib
Biogen Looks at Former J&J Exec as Potential CEO Candidate
BioSpace
Mon, 10/10/22 - 07:00 pm
Tags:
Biogen
,
Pharma CEOs
,
JNJ
,
Mathai Mammen
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks
,
AbbVie
,
Alnylam
,
AstraZeneca
,
Biogen
,
CRISPR Therapeutics
,
Daiichi Sankyo
,
Eisai
,
Eli Lilly
,
GSK
,
Intellia Therapeutics
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
Biogen, Denali begin late-stage testing of Parkinson’s drug
BioPharma Dive
Mon, 10/3/22 - 11:28 pm
Tags:
Biogen
,
Denali Therapeutics
,
Parkinson's Disease
,
clinical trials
,
BIIB122
Medicare Part B premiums to drop 3% next year, partly due to limited Aduhelm coverage
Medical Marketing and Media
Thu, 09/29/22 - 10:23 am
Tags:
Medicare
,
Medicare Part B
,
Biogen
,
Aduhelm
Biotech’s near-term key catalysts
EP Vantage
Thu, 09/29/22 - 09:45 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
Arrowhead Pharmaceuticals
,
Takeda
,
RNAi
,
Madrigal
,
NASH
,
Ascendis
,
FDA
Lecanemab can; now the wait for details begins
EP Vantage
Wed, 09/28/22 - 11:45 am
Tags:
Biogen
,
Eisai
,
lecanemab
,
clinical trials
,
Alzheimer's disease
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.